medigraphic.com
ISSN 1561-2945 (Print)

2014, Number 2

<< Back Next >>

Revista Cubana de Cirugía 2014; 53 (2)

Pulmonary Malt lymphoma: case report and literature review

Nazario DAM, Domínguez GEJ, García OL, Matos TM, Falcón VC

Language: Spanish
References: 10
Page: 176-181
PDF size: 105.91 Kb.


ABSTRACT

Primary pulmonary lymphoma is very uncommon, representing only 0.5 – 1 % of malignant lung tumoral malignancies. Here is a patient with histologically confirmed lung MALT lymphoma, who was operated on at “Saturnino Lora Torres” hospital in Santiago de Cuba province. The patient was followed up by the surgery and oncology service and he was disease-free for over three years. Malt-type lymphoma is rare, its diagnosis before surgery is practically non-existent, which hinders proper management of a case.


REFERENCES

  1. Salinas Aj, Leiva Ri, González B. Proliferaciones linforreticulares del pulmón. Rev Chil Enferm Respir. 2006 [Citado octubre 2013];22(2). Disponible en: http://www.scielo.cl/scielo.php?pid=S0717-73482006000200006&script=sci_arttext

  2. Botana Rial M, Fernández-Villar A, Leiro Fernández V, Represas Represas C, y cols. linfoma Malt pulmonar en una paciente con artritis reumatoide. Pneuma. 2007;8:50-2.

  3. Chilosi M, Zinzani PL, Poletti V. Lymphoproliferative lung disorders. Semin Respir Crit Care Medicine. 2005;26:490-501.

  4. Cadrenal J, Wislez M, Antonie M. Primary pulmonary lymphoma. Eur Respir J. 2002;20:750-62.

  5. Ahmed S, Kussic SJ, Siddiqui AK, Bhuiya TA, Kahn A, Sarewitz S, et al. Bronchialassociated lymphoid tissue lymphoma. A clinical study of a rare disease. Eu J Cancer. 2004;40:1320-6.

  6. Guinee DG Jr. Update on Nonneoplastic Pulmonary Lymphoproliferative Disorders and Related Entities. Arch Pathol Lab Med. 2010;134:691-701.

  7. Ucar GM. Ibañez OB. Ferrari CR. Pollono FD. Tumores pulmonares en pediatría. Rev Chil Enferm Respir. 2012 [Citado octubre 2013];28(3).

  8. PET/CT en la estadificación y respuesta al tratamiento. Publicación oficial de la Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear; 2013. [Citado octubre 2013]. Disponible en: http://www.alasbimnjournal.net/contenidos/conceptualizando-viii-papel-de-la-18-ffdg- en-la-estadificacion-y-respuesta-al-tratamiento-del-linfoma-en-ninos-yadolescentes- con-enfoque-en-el-lnh-119?cap=pet-ct-en-la-estadificacion-y-respuestaal- tratamiento

  9. Dunleavy K, Wilson WH. Diagnosis and treatment of non-Hodgkin lymphoma (aggressive). In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Elsevier; 2009. p. 1293-302.

  10. Evens AM, Winter JN, Gordon LI, et al. Non-Hodgkin lymphoma. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, eds. Cancer Management: A Multidisciplinary Approach. 13th ed. Lawrence, KS: UBM Medica; 2010. p. 739-94.




2020     |     www.medigraphic.com